BioHouston Annual Luncheon--October 13, 2009
The Annual Luncheon is attended by the Who’s Who of the Houston’s life science community and includes keynote addresses from prominent industry leaders. Past Luncheon speakers have included:
--Dr. Elsa A. Murano, President, Texas A&M University
--Ivor Royston, M.D., Co-Founder of Hybritech & Partner of Forward Ventures
--Andrew von Eschenbach, M.D., Commissioner of the FDA
--Stephen Gillis, Ph.D., ARCH Venture Partners & Founder of Corixa and Immunex
|
The TLSC showcases the region and state’s entrepreneurial spirit and leading start-up companies. This conference brings together more than 300 of the life science industry’s preeminent venture capitalists, leading researchers, and emerging company executives, representing some of the most revolutionary developments in the life sciences.
|
BioHouston is supported annually through corporate memberships. Membership benefits are myriad—to view membership benefits and join, click here.
BIOHOUSTON RESOURCE CENTER
The BioHouston Resource Center (BRC) makes it easier and more affordable for start-up companies to get to work producing proof-of-concept data, by providing access to wet lab bench space, shared equipment, and the offices and tools that start-up companies need. For more information, click here.
Your support is needed—for more information, click here.
2008 Winner
Visualase, Inc. was the winner of the 2008 Michael E. DeBakey Memorial Life Science Award. Visualase, Inc. is focused on product development, clinical evaluations, manufacturing, and marketing of advanced laser and image-guided technologies for thermal ablation markets. Judged by national and local venture capitalists attending the 2008 Texas Life Science Conference, Visualase was selected over its peers as having the best potential for commercialization. In addition to the cash prize, Visualase will receive a pro bono provisional patent filing from Baker & McKenzie LLP and premier visibility for the year in all BioHouston programs. To provide further support, BioHouston will offer low cost, short-term office space to help further close the funding gaps typically faced by these companies. Lastly, after coaching by a select group of national and local venture capitalists for 2009, Visualase will attend a national venture conference with BioHoustonin 2010.
CURRENT BIOTECH NEWS
|
 |
Stem Cell Funding News
Ashley Dombkowski of MPM Capital and BIO's CEO Jim Greenwood discuss whether President Obama's greenlighting of government funding towards stem cell research signals an opportunity for investors in this CNBC report.
Specialized life science facilities and land available near the Texas Medical Center
Purchase the 2007/2008 Life Science Directory
|
